| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/13/2008 | EP1641483B1 Fusion proteins |
| 02/13/2008 | EP1615656B9 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same |
| 02/13/2008 | EP1578915A4 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 02/13/2008 | EP1553972A4 Method of treating chronic pelvic pain syndrome by administration of chrorionic gonadotropin |
| 02/13/2008 | EP1543109B1 Substances for preventing and treating autoimmune diseases |
| 02/13/2008 | EP1529061B1 Method for isolating an intestinal cholesterol binding protein |
| 02/13/2008 | EP1517699B1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 02/13/2008 | EP1476752A4 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
| 02/13/2008 | EP1424985B1 Use of derivatives of c2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or the treatment of obesity |
| 02/13/2008 | EP1417223B8 Process for preparing lipid ii |
| 02/13/2008 | EP1379283B1 Identification of target-specific folding sites in peptides and proteins |
| 02/13/2008 | EP1297843B1 Method of photoreduction of hemoglobin vesicles |
| 02/13/2008 | EP1292328B1 Chimeric human papillomavirus (hpv) l1 molecules and uses therefor |
| 02/13/2008 | EP1272643B1 Talaromyces emersonii beta-glucanases |
| 02/13/2008 | EP1207200B1 High affinity choline transporter |
| 02/13/2008 | EP1168934B1 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 02/13/2008 | EP1105467B9 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 02/13/2008 | EP1082126B1 Novel peptides |
| 02/13/2008 | EP0833652B1 Novel kappa receptor selective opioid peptides |
| 02/13/2008 | EP0797662B1 Methods for treatment or diagnosis of diseases or conditions associated with abnormal signal transduction |
| 02/13/2008 | EP0755454B1 Aav-mediated delivery of dna to cells of the nervous system |
| 02/13/2008 | CN101124331A Site-directed modification of FVIII |
| 02/13/2008 | CN101124327A Modified CEA/B7 vector |
| 02/13/2008 | CN101124261A Casein derived peptides and therapeutic uses thereof |
| 02/13/2008 | CN101124243A Conjugation product |
| 02/13/2008 | CN101124240A Specific binding agents to hepatocyte growth factor |
| 02/13/2008 | CN101124239A Modulation of ovulation |
| 02/13/2008 | CN101124215A Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders |
| 02/13/2008 | CN101123988A Sustained release composition of protein drug |
| 02/13/2008 | CN101123986A Glucocerebroside treatment of disease |
| 02/13/2008 | CN101123979A Treatment of hepatitis c in the asian population with interferon-beta |
| 02/13/2008 | CN101123978A Neublastin variants |
| 02/13/2008 | CN101123977A Compositions for induction of a therapeutic response |
| 02/13/2008 | CN101123879A Methods for treatment of angiogenesis |
| 02/13/2008 | CN101123878A L-threonine derivatives of high therapeutic index |
| 02/13/2008 | CN101121935A Chlamys farreri serine protease inhibitor CfKZSPI gene and its coding protein and application |
| 02/13/2008 | CN101121753A Human serum albumin recombination fusion protein with continuous repairing function to multifarious skin cell |
| 02/13/2008 | CN101121751A PTD-tyrosine hydroxylase catalysis region fusion protein and application thereof |
| 02/13/2008 | CN101121749A Gamma-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 02/13/2008 | CN101121745A Small molecular acidity peptide, extraction method thereof and pharmaceutical composition using the same as active ingredient |
| 02/13/2008 | CN101121020A Anti-gp39 antibodies and its uses |
| 02/13/2008 | CN101121019A Use of division deficient protein 3 |
| 02/13/2008 | CN101121018A Application of recombination FN polypeptide in preparing medicine for treating severe infectious diseases such as septicemia |
| 02/13/2008 | CN100368550C High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site |
| 02/13/2008 | CN100368547C Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 02/13/2008 | CN100368540C Production method for recombinant cytoglobin and uses thereof |
| 02/13/2008 | CN100368537C Prepn. process for freezing dry powder of bromelain |
| 02/13/2008 | CN100368436C Molecular design and prepn process of recombinant polyepitope chimeric peptide CP22 antigen of human chorionic gonadotropin |
| 02/13/2008 | CN100368435C Arf6 activator protein and its coding gene and application |
| 02/13/2008 | CN100368433C Bean-potato antitumour protein |
| 02/13/2008 | CN100368431C Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumors |
| 02/13/2008 | CN100368020C Compositions for stimulating cytokine secretion and inducing an immune response |
| 02/13/2008 | CN100368018C Fumor invasion and metastasis resisting function and use of venin cysteine proteinase inhibitor |
| 02/13/2008 | CN100368017C Compound bioogic component and pharmaceutical preparation possessing function for accelerating hemoglutination |
| 02/13/2008 | CN100368016C Infusion liquid for treating cow mastitis and preparation method thereof |
| 02/13/2008 | CN100368015C Medicine for relieving drunk |
| 02/13/2008 | CN100368014C Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 02/13/2008 | CN100368013C Aqueous preparation containing oligopeptides and etherified cyclodextrin |
| 02/12/2008 | USRE40059 Sensitive substance encapsulation |
| 02/12/2008 | US7329740 Flk-1 binding protein |
| 02/12/2008 | US7329733 Bacillus thuringiensis strain, crystal gene and crystal protein and uses thereof |
| 02/12/2008 | US7329732 HCV RNA-dependent RNA polymerase |
| 02/12/2008 | US7329731 Soluble T cell receptor |
| 02/12/2008 | US7329729 Secreted epithelial colon stromal-1 molecules and uses thereof |
| 02/12/2008 | US7329728 Ligand activated transcriptional regulator proteins |
| 02/12/2008 | US7329726 Physiologically active peptides |
| 02/12/2008 | US7329725 For discovering peptide ligands that bind to and antagonize disease-associated receptors or ligands |
| 02/12/2008 | US7329724 For therapy of hemophilia; liquid at a specific pH range of acidity |
| 02/12/2008 | US7329650 Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases |
| 02/12/2008 | US7329649 Combinatorial methods for inducing cancer cell death |
| 02/12/2008 | US7329646 recombinant methods; |
| 02/12/2008 | US7329645 TGF-α polypeptides, functional fragments and methods of use therefor |
| 02/12/2008 | US7329644 Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours |
| 02/12/2008 | US7329643 Inhibition of HMGB1 release by fetuin |
| 02/12/2008 | US7329642 Therapeutic treatment with antitumor agent or antiproliferative agent, preventing neovascularization into the tissue |
| 02/12/2008 | US7329641 Blood substitutes |
| 02/12/2008 | US7329640 Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor |
| 02/12/2008 | US7329639 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; diagnosing and treating cancer; cancer vaccines |
| 02/12/2008 | US7329638 Drug delivery compositions |
| 02/12/2008 | US7329543 Red blood cells loaded with S-nitrosothiol and uses therefor |
| 02/12/2008 | US7329541 Zinc finger binding domains for GNN |
| 02/12/2008 | US7329540 Corneodesmosin based test and model for inflammatory disease |
| 02/12/2008 | US7329516 Methods for increasing protein polyethylene glycol (PEG) conjugation |
| 02/12/2008 | US7329512 found in natural rubber that can induce an allergic reaction in persons who have been sensitised to it; for determining molecular weight, isoelectric point, amino acid sequence and allergenicity; for immunoassay/therapy |
| 02/12/2008 | US7329511 Nucleic acid encoding GAD65 |
| 02/12/2008 | US7329510 Containing specific DNA sequence; use in the therapy of disorders selected from human psychiatric and neurological disroders, cardiiovascular disorder, and reproductive dysfunction |
| 02/12/2008 | US7329507 Linking oligopeptide to a stabilizing group, linking the oligopeptide to a therapeutic agent, testing if the conjugate is cleavable by Thimet oligopeptidase |
| 02/12/2008 | US7329505 Specific detection of proteolytic enzymes |
| 02/12/2008 | US7329500 Moraxella (Branhamella) catarrhalis polypeptides and corresponding DNA fragments |
| 02/12/2008 | US7329499 Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes |
| 02/12/2008 | US7329498 Identifying a T-cell epitope in protein, modifying protein to neutralize T-cell epitope such that the modified protein induces less than or substantially equal the baseline proliferation of naive T-cells, and wherein the allergenicity of protein is reduced |
| 02/12/2008 | US7329410 Compositions and method for WT1 specific immunotherapy |
| 02/12/2008 | US7329406 Methods of treating psoriasis with αvβ3-specific antibodies |
| 02/12/2008 | CA2319638C Electrotransport electrode assembly having lower initial resistance |
| 02/12/2008 | CA2315532C Cyclopeptide derivatives with integrin inhibitor properties |
| 02/12/2008 | CA2303432C Modulation of drug loading in multivesicular liposomes |
| 02/12/2008 | CA2234716C Peptides for treatment of inflammation and shock |
| 02/12/2008 | CA2203246C Alk-7 (activin like kinase), a serine threonine kinase receptor |
| 02/12/2008 | CA2202137C Composition, device and method for enhanced electrotransport agent delivery |
| 02/12/2008 | CA2190802C A method of preparing and recovering proteins |